XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2022   $ 2,700 $ 1,094,236 $ 8,857,485 $ (368,124) $ (206,821)   $ (1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   7            
Issuance of common stock under employee stock plans     6,824         13,860
Share-based compensation expense     22,860          
Net income $ 629,954     629,954        
Cash dividends paid       (115,071)        
Other       0        
Translation adjustments         62,660      
Change in long-term intercompany notes         5,903      
Net investment hedge instruments gain (loss), net of tax of $(930) and $2,317 for the quarter ended June 30, 2024 and 2023, and $(4,917) and $6,122 for the six months ended June 30, 2024 and 2023, respectively         (18,798)      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended June 30, 2024 and 2023 and $(730) and $(1,036) for the six months ended June 30, 2024 and 2023 , respectively           3,184    
Purchase of treasury stock               (6,524)
Balance at the end of the year at Jun. 30, 2023 8,081,371 2,707 1,123,920 9,372,368 (318,359) (203,637) $ (521,996) (1,895,628)
Balance at the beginning of the year at Mar. 31, 2023   2,704 1,092,362 9,105,705 (343,217) (205,229)   (1,895,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   3            
Issuance of common stock under employee stock plans     18,977         (406)
Share-based compensation expense     12,581          
Net income 324,242     324,242        
Cash dividends paid       (57,579)        
Other       0        
Translation adjustments         29,840      
Change in long-term intercompany notes         2,132      
Net investment hedge instruments gain (loss), net of tax of $(930) and $2,317 for the quarter ended June 30, 2024 and 2023, and $(4,917) and $6,122 for the six months ended June 30, 2024 and 2023, respectively         (7,114)      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended June 30, 2024 and 2023 and $(730) and $(1,036) for the six months ended June 30, 2024 and 2023 , respectively           1,592    
Purchase of treasury stock               (22)
Balance at the end of the year at Jun. 30, 2023 8,081,371 2,707 1,123,920 9,372,368 (318,359) (203,637) (521,996) (1,895,628)
Balance at the beginning of the year at Dec. 31, 2023 8,730,191 2,709 1,168,694 9,940,343 (298,835) (186,107)   (1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   7            
Issuance of common stock under employee stock plans     19,556         6,319
Share-based compensation expense     22,164          
Net income 648,626     648,626        
Cash dividends paid       (129,411)        
Other       (2)        
Translation adjustments         (50,821)      
Change in long-term intercompany notes         (4,048)      
Net investment hedge instruments gain (loss), net of tax of $(930) and $2,317 for the quarter ended June 30, 2024 and 2023, and $(4,917) and $6,122 for the six months ended June 30, 2024 and 2023, respectively         15,098      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended June 30, 2024 and 2023 and $(730) and $(1,036) for the six months ended June 30, 2024 and 2023 , respectively           2,320    
Purchase of treasury stock               (7,595)
Balance at the end of the year at Jun. 30, 2024 9,252,404 2,716 1,210,414 10,459,556 (338,606) (183,787) (522,393) (1,897,889)
Balance at the beginning of the year at Mar. 31, 2024   2,715 1,186,132 10,186,621 (325,381) (184,947)   (1,896,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     11,059         (284)
Share-based compensation expense     13,223          
Net income 337,683     337,683        
Cash dividends paid       (64,747)        
Other       (1)        
Translation adjustments         (16,706)      
Change in long-term intercompany notes         625      
Net investment hedge instruments gain (loss), net of tax of $(930) and $2,317 for the quarter ended June 30, 2024 and 2023, and $(4,917) and $6,122 for the six months ended June 30, 2024 and 2023, respectively         2,856      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended June 30, 2024 and 2023 and $(730) and $(1,036) for the six months ended June 30, 2024 and 2023 , respectively           1,160    
Purchase of treasury stock               (680)
Balance at the end of the year at Jun. 30, 2024 $ 9,252,404 $ 2,716 $ 1,210,414 $ 10,459,556 $ (338,606) $ (183,787) $ (522,393) $ (1,897,889)